Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategies.

Séguy L, Guyon L, Corvaisier S, Maurel M, Verdié P, Herbinet R, Pluart LL, Dehouck L, Sevin E, Fenart L, Gosselet F, Lagadu S, Née G, Fréret T, Since M, Delépée R, Dallemagne P, Lisowski V, Groo AC, Malzert-Fréon A

Open source

DOI: 10.1016/j.ijpharm.2026.127181
Published: 2026 Sep 5
Container: International journal of pharmaceutics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2026.127181,
  title = {Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategies.},
  author = {Séguy L and Guyon L and Corvaisier S and Maurel M and Verdié P and Herbinet R and Pluart LL and Dehouck L and Sevin E and Fenart L and Gosselet F and Lagadu S and Née G and Fréret T and Since M and Delépée R and Dallemagne P and Lisowski V and Groo AC and Malzert-Fréon A},
  year = {2026},
  journal = {International journal of pharmaceutics},
  doi = {10.1016/j.ijpharm.2026.127181},
  url = {https://doi.org/10.1016/j.ijpharm.2026.127181}
}

RIS

TY  - JOUR
TI  - Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategies.
AU  - Séguy L
AU  - Guyon L
AU  - Corvaisier S
AU  - Maurel M
AU  - Verdié P
AU  - Herbinet R
AU  - Pluart LL
AU  - Dehouck L
AU  - Sevin E
AU  - Fenart L
AU  - Gosselet F
AU  - Lagadu S
AU  - Née G
AU  - Fréret T
AU  - Since M
AU  - Delépée R
AU  - Dallemagne P
AU  - Lisowski V
AU  - Groo AC
AU  - Malzert-Fréon A
PY  - 2026
JO  - International journal of pharmaceutics
DO  - 10.1016/j.ijpharm.2026.127181
UR  - https://doi.org/10.1016/j.ijpharm.2026.127181
ER  -

APA

L, S., L, G., S, C., M, M., P, V., R, H., LL, P., L, D., E, S., L, F., F, G., S, L., G, N., T, F., M, S., R, D., P, D., V, L., AC, G., & A, M. (2026). Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategies.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127181

Source records

pubmed · retrieved 2026-09-26T10:22:30.677Z